Human cytomegalovirus (HCMV) strains can be classified into different glycoprotein B (gB) genotypes. In a previous study, frequent intragenic variation of the gB gene was shown. The aim of this study was to analyse whether gB variation was due to homologous recombination. The gB gene of DNA extracts derived from the peripheral blood leukocytes of 14 immunosuppressed patients was amplified by PCR and cloned. Three variable sites of gB were analysed by restriction fragment analysis and DNA sequencing and compared with published prototypic strains. In three patients doubly infected with two distinct HCMV gB strains, prototypic (60-85 %) and nonprototypic recombinant strains (5-40 %) were detected. To demonstrate that homologous recombination is driving HCMV gB variability, cells were coinfected with plaque-purified prototypic gB strains and recombinant gB genes were selectively amplified by PCR. gB recombinants were detected after 15 days of coculture and cross-over sites were determined by sequencing. These data indicate that homologous recombination contributes to the variability of the gB gene in vitro and in vivo.
Introduction
Glycoprotein B (gB) of human cytomegalovirus (HCMV) is a major component of the virion envelope and is transported to the plasma membrane of infected cells. The gB precursor protein of 906 amino acids undergoes glycosylation and proteolytic cleavage between residues 460 and 461. The surface subunit gp116 and the transmembrane subunit gp55 are disufide-bonded. gB plays an important role in virus infectivity and cell-to-cell spread, and is a major target for antibody-mediated immunity (Navarro et al., 1993 ; Britt et al., 1990 ; Utz et al., 1989) . The linear epitopes AD1 (located on gp 55) and AD2 (located at the N terminus of gp116) bind virus-neutralizing antibodies (Britt & Mach, 1996 ; Spaete et al., 1988) .
There are several variable regions of gB, and HCMV strains have been classified into four genotypes based on restriction fragment length polymorphism (RFLP) of a fragment corresponding to the cleavage site (Chou & Dennison, 1991 ; Chou, 1992) . This genotyping scheme has been used to correlate the outcome of HCMV infection with specific gB strains in clinical studies. Some studies found that specific gB types were associated with a higher incidence of severe Author for correspondence : Frank Hufert.
Fax j49 761 203 6603. e-mail hufert!ukl.uni-freiburg.de HCMV infections, whereas others could not confirm these results (Fries et al., 1994 ; Bongarts et al., 1996 ; Vogelberg et al., 1996 ; Rasmussen et al., 1997) .
Recently, evidence of new strains arising in individuals infected with multiple HCMV strains and intragenic variation within gB was obtained (Chou, 1989 (Chou, , 1992 . We previously determined the genotype at three variable sites of the gB gene using samples from immunosuppressed subjects. Fragments corresponding to AD2 at the N terminus (gBn) of gp116 and the cleavage site (gBcls) and C terminus (gBc) of gp55 were analysed and four gBn genotypes, four gBcls types and two gBc types were discriminated by comparison with published strains defined as prototypic . We found that the gB genotype determined at the cleavage site was frequently different from gBn and\or gBc types, indicating that a high number of non-prototypic strains exist (MeyerKo$ nig et al., 1998 a) . Here we show that these gB virus variants were generated by homologous recombination.
These results have been presented in part at the Sixth International Cytomegalovirus Workshop, Perdido Beach Resort, Alabama, USA (March, 1997).
Methods
Patients. The samples were obtained from immunosuppressed patients during routine screening as described previously . Here, the blood samples from six bone marrow transplant M. Haberland, U. Meyer-Ko$ nig and F. T. Hufert M. Haberland, U. Meyer-Ko$ nig and F. T. Hufert recipients, five kidney transplant recipients, three AIDS patients, two lung transplant recipients and one heart transplant recipient were investigated. Three of these patients (one lung transplant recipient and two AIDS patients) were found to be infected with two different HCMV gB strains.
Cells and viruses.
Two clinical isolates previously found to be prototypic (N1 and N12, GenBank accession nos AJ006981 and AJ006982, respectively) were plaque-purified . Strain N1 represented a gB prototype I (gBn1-gBcls1-gBc1\2) and strain N12 represented a gB prototype II (gBn2-gBcls2-gBc1\2). In detail, human foreskin fibroblasts (HFF) were infected at an m.o.i. of 1, overlaid with 0n6 % agarose (Serva), cultured at 37 mC until cytopathic effect (CPE) was visible and single cells with CPE were then picked and used to infect HFF. Infected cells were harvested after two to three passages and used for DNA sequencing or coculture experiments.
For coculture experiments, HFF were infected with a mixture of strain N1 and strain N12 at an m.o.i. of 1 each. Supernatant and infected HFF were then checked daily for recombinant viruses by selective PCR. To prove viability of recombinant viruses, supernatant was harvested at day 20 after coculture and a plaque assay was performed. A total of 96 plaques were picked and HFF grown in 48-well plates were inoculated and incubated until CPE was visible. The supernatant was checked again for recombinant viruses by selective PCR.
DNA preparation, cloning and genotyping. Peripheral blood leukocytes (PBL) were separated as described (Meyer-Ko$ nig et al., 1995) . DNA of PBL and infected HFF was prepared and the entire gB gene was amplified by nested PCR using primers gBallout 5' and 3' followed by primers gBallin 5' and 3' as described .
Amplification products were analysed by electrophoresis on a 1n0% agarose gel stained with ethidium bromide, and the DNA was excised for cloning. Fragments were purified (Quiaquick gel extraction kit, Qiagen), ligated into the cloning vector (plasmid pCR2.1) and E. coli was transfected using the TA cloning kit (Invitrogen). Bacteria were grown overnight, colonies were picked and DNA was purified. The fragments were then amplified by primer sets gBallin5'\gB1604 (gBn), gB 1319\1604 (gBcls) and gB 1319\gBallin3' (gBc) as described (MeyerKo$ nig et al., 1998 a) .
The gBcls types (type 1-4) were determined by RFLP as published (Chou & Dennison, 1991) . To determine gBn and gBc types, sequences were aligned with previously described prototypic gB strains (Chou & Dennison, 1991 ; Chou, 1992) .
Selective PCR for detection of recombinant genes. HFF cocultured with strains N1 and N12 were screened daily for recombinant genes by selective PCR until day 21 after coculture. Primers were designed in order to selectively amplify target sequences with a gBn 1 configuration at the N terminus and a gBcls 2 configuration at the cleavage site (primers gBN-1, ACTCTCGATCCGGTTCAGTC, and gBCl-2, CTTCTGGTCCTATGAGTGAT). The amplification product was detected 15 days after coinfection. PCR was performed using 2 U TaqGold (PE-ABI) in a hot-start time-release assay. The reaction mixture was incubated for 3 min at 96 mC to denature DNA. Amplification was performed in 45 cycles for 30 s at 94 mC, for 15 s at a gradually reduced annealing temperature (68 mC for 10 cycles, 63 mC for 10 cycles and 55 mC for 25 cycles) and for 90 s at 72 mC. A positive control for each PCR reaction consisted of a plasmid containing a recombinant gB gene (pCR2.1gB121) ; negative controls consisted of plasmids containing nonrecombinant gB 1 and 2 prototypes (pCR2.1gB111 and pCR2.1gB221), mock infected HFF and cells infected with a single gB strain.
DNA sequencing of cross-over sites. To define the cross-over sites of recombination, the amplification product of the selective PCR was then cloned and eight clones were sequenced with sequencing primers gBN-1, gBNi3 (CGTCAAAACATTTTGGTAGACCCG), gBNo3' (GT-AGCTGGCATTGCGATTGG), gB2o5' (GCAGCACCTGGCTCTAT-CG) and gBCl-2. Sequences were aligned and compared with the original sequences from strain I (gBn1-gBcls1-gBc1\2) and strain II (gBn2-gBcls2-gBc1\2) used for coinfection.
Results

Intra-and interpatient variability of the gB genotypes
We assessed the intra-and interpatient variability of HCMV gB strains derived from the PBL of 14 immunosuppressed HCMV-infected patients. The DNA of PBL was extracted and the entire gB gene was amplified and cloned as described above. The gBn, gBcls and gBc types were analysed in a total of six clones from each patient.
Multiple combinations of the different gB types at the three investigated gene regions occurred in different patients (Fig. 1 ). In eight of 14 patients the gB type determined at the cleavage site was different from gBn and\or gBc types. Except for one individual, intrapatient similarity of all clones was 100 %. The variability of clones derived from the three gene regions of different patients with the same gB configuration (gBn1-gBcls1-gBc1\2 and gBn3-gBcls2-gBc1\2) ranged from 97 % to 99 %. This allowed us to identify individual strain differences by point mutations. However, in one patient a second virus variant could be detected. Here, one out of six clones showed a gBn 1 genotype, whereas five clones were typed as gBn 4 genotype (Fig. 1) .
Detection of homologous recombination in doubleinfected patients
We then investigated whether in double-infected patients virus variants could be detected which might be due to homologous recombination.
Immunosuppressed patients were screened for double infections with different HCMV gB strains. The gB gene was amplified by PCR directly from the PBL of viraemic patients and the gBcls type was determined by RFLP. In three patients the restriction pattern could not be assigned to one of the four gBcls types, indicating the presence of two or more genotypes in one blood sample. To resolve the mixture of gBcls types in these samples, a PCR-based limited dilution RFLP assay was performed as described previously (Meyer-Ko$ nig et al., 1998 c) . Briefly, tenfold dilutions of the first round amplification product were made up to the point where only 50 % of several second round amplifications gave a positive signal. From those amplification products, 20 reactions were typed by RFLP and the mixture of genotypes could be resolved. Three patients were found to be infected with a mixture of gBcls types 1 and 2. The entire gB gene was amplified using DNA from PBL and cloned into pCR2.1. A total of 20 clones was examined for each patient. The genotype of all clones was determined (gBcls types by RFLP, gBn and gBc types by sequence analysis). As Fig. 1 . Variability of gB genotypes in HCMV strains derived from PBL of 14 immunosuppressed patients. A total of six clones from each patient was analysed. The genotype at the cleavage site of gB (gBcls) was determined by RFLP as described. The genotypes at the N terminus (gBn) and the C terminus (gBc) were determined by sequencing using the following sequencing primers : gBNi5h (bp k6-18), gBNi3h (bp 421-444), gBCi5h (bp 2032-2050) and gBCi3h (bp 2515-2534). The bp numbering refers to the AD169 gB gene with 1 being the first bp of the gB start codon.
shown in Fig. 2 , patients 1 and 2 had a mixture of nonrecombinant and recombinant clones (gBn 1 and gBcls 2). Patient 3 showed a mixture of all possible variants (nonrecombinant gB 1 and 2 clones, two recombinants with gBn1-gBcls2 configuration, and one recombinant with gBn2-gBcls1 configuration). Within one patient all clones of one gB genotype showed sequence identity of 100 %, whereas the same genotypes between different patients could be distinguished by distinct point mutations.
Detection of homologous recombination in tissue culture
To study whether homologous recombination events could be found in vitro, a coinfection experiment was performed. Two clinical isolates representing prototype I (gBn1-gBcls1-gBc1\2) and prototype II (gBn2-gBcls2-gBc1\2) were plaquepurified and sequenced. HFF were then coinfected and screened daily for recombinant genes by selective PCR. An amplification product was first detected 15 days after coculture (Fig. 3) . Sequences were aligned and compared with the original sequences from prototype I (gBn1-gBcls1-gBc1\2) and prototype II (gBn2-gBcls2-gBc1\2) used for coinfection. Seven out of eight clones had an identity of 100 % with gB prototype Fig. 2 . Homologous recombination in doubly infected patients. HCMV DNA derived from the PBL of three doubly infected patients was cloned and a total of 20 clones from each patient was analysed. The genotype at the cleavage site of gB (gBcls) was determined by RFLP as described. The genotypes at the N terminus (gBn) and the C terminus (gBc) were determined by sequencing using the following sequencing primers : gBNi5h (bp k6-18), gBNi3h (bp 421-444), gBCi5h (bp 2032-2050) and gBCi3h (bp 2515-2534). The bp numbering refers to the AD169 gB gene with 1 being the first bp of the gB start codon.
I for the first 761 bp. The clones crossed over to the gB 2 genotype between bp 761 and 1158 (Fig. 4) . Additionally, clone 5 showed a gene cassette of 66 bp with 100 % identity to gB type 2.
To analyse the viability and the percentage of progeny virus with recombinant genes, a plaque assay was performed at day 20 after coculture. A total of 96 plaques were picked and the virus was reisolated on HFF. Reisolation of 76 of 96 plaques was successful and recombinant gB genes were detected by selective PCR in 37 of 76 virus isolates (49 %). These results demonstrate that the in vitro generation of HCMV strains with recombinant gB genes is not a rare event.
It has been previously described that recombinants may be generated artificially by PCR (Meyerhans et al., 1990) . To estimate the frequency of PCR-generated recombinants in our assay, we amplified an equimolar mixture of different plasmids by selective PCR and no amplification product was obtained (data not shown). We then amplified the entire gB gene of the plasmid mixture by PCR, the amplification product was cloned, and 25 positive clones were screened for recombinant genes by selective PCR. No recombinants could be detected. This clearly shows that artificial recombination due to PCR is, if it occurs at all, a very rare event.
BEJH M. Haberland, U. Meyer-Ko$ nig and F. T. Hufert M. Haberland, U. Meyer-Ko$ nig and F. T. Hufert Fig. 3 . Homologous recombination in tissue culture detected by selective PCR. (A) Human foreskin fibroblasts (HFF) were coinfected with prototype I (gBn1-gBcls1-gBc1/2) and prototype II (gBn2-gBcls2-gBc1/2) as described in the text. Cultures were screened by PCR which selectively amplified target sequences with a gBn 1 configuration at the N terminus and a gBcls 2 configuration at the cleavage site of gB for 21 days after coculture (d0-d21). The amplification product of 1233 bp was first detected at day 15 after coculture. MW, molecular mass marker. (B) A positive control for each PCR reaction consisted of plasmid pCR2.1gB121, which contains a recombinant gB gene. Fig. 4 . Homologous recombination of prototype strains after coculture. Recombinant genes were amplified selectively by PCR as described in the text. To define the cross-over sites, the amplification product was cloned and eight clones were sequenced between bp 143 and bp 1376 using the following sequencing primers : gBNi3h (bp 421-444), gBNo3h (bp 848-867), gB2o5h (bp 710-728), gBN1 (bp 143-159) and gBCl-2 (bp 1357-1376). The bp numbering refers to strain AD169.
Discussion
Accurate identification of HCMV strains is required to study the epidemiology and pathogenesis of HCMV infection. For this purpose, typing of the HCMV gB gene is useful since only a limited number of different HCMV gB strains circulate in the population (Chou & Dennison, 1991) . In a previous study we analysed the interpatient variability of the HCMV gB gene. The gB genotype was determined at three variable sites and it was found that strains frequently differ from prototypic strains at one or more of these sites . These virus variants may be generated by homologous recombination. To address this question, we first investigated the intrapatient gB variability of patients with HCMV viraemia. Variable fragments corresponding to the N terminus (gBn), the cleavage site (gBcls) and the C terminus (gBc) of gB were analysed. PCR and DNA sequencing was performed using different clones derived from the PBL of 14 immunosuppressed patients. The intrapatient variability was low since only one of 14 patients was found to be infected with a second virus variant. However, point mutations in clones derived from different patients infected with the same gB strain allowed us to identify individual strain differences.
To search for virus strains generated by homologous recombination, the PBL of patients doubly infected with two different HCMV gB strains were then analysed. In one of these patients we found HCMV prototypes I and prototypes II. In addition, non-prototypic strains in which the N terminal region of gB was exchanged for either a gBn 1 or a gBn 2 genotype were also found. Sequence identity was 100 % for clones with a gBn 1 genotype and for those with a gBn 2 genotype. It could be argued that the non-prototypic strains were either derived from superinfection with different strains or the result of homologous recombination between prototypic strains. Since we were usually able to discriminate individual strain differences it is more likely that the non-prototypic strains were generated by homologous recombination.
Unfortunately, an animal model for HCMV infection is still lacking. Thus, coinfection experiments with defined prototypic strains in a susceptible host cannot be carried out. To solve this problem, we used the tissue culture system to look for the generation of recombinant viruses. Indeed, we were able to find recombinant HCMV gB strains 15 days after double infection of HFF with two different prototypic strains. Plaque purification demonstrated the viability of the recombinant strains and showed that after coculture 49 % of progeny is recombinant. It has been described that up to 5 % of the amplified fragments were artificial recombinants when amplification was performed with two different target sequences using short elongation times (Meyerhans et al., 1990) . However, we could not find any PCR-generated recombinants in our assay because the amplification of equimolar plasmid mixtures was negative in the selective PCR assay. From these data we conclude that recombination of the gB gene was not a PCR artefact. Homologous recombination has been described for herpes simplex virus (HSV) and Epstein-Barr virus (EBV). In the mouse model of HSV, mixed infection with two non-virulent HSV strains differing in their gB gene sequences led to increased virulence due to interstrain recombination (Lingen et al., 1997) . In EBV infection, intrastrain recombination has been described for EBNA-2 genes in patients with oral hairy leukoplakia . Taking all the data together, one may consider recombination as a herpesviruses mechanism to gain variability in the host.
For HCMV, several mechanisms to escape cellular immune attack have recently been described (Wiertz et al., 1996 a, b ; Hengel et al., 1996 ; Farrell et al., 1997) . However, mechanisms of HCMV to escape humoral immune response, as shown for human immunodeficiency virus, have not been described (Schreiber et al., 1997) . Neutralizing antibodies bind to several conformation-dependent antigenic epitopes of gB and to the linear epitopes within antigenic domains AD1 and AD2 (Britt & Mach, 1996 ; Spaete et al., 1988) . The cross-neutralization activity of monoclonal antibodies directed against these epitopes has not been investigated using different clinical HCMV strains. However, it has been shown that binding of monoclonal antibodies and of human serum antibodies to AD2 differs between laboratory and clinical HCMV strains (Meyer et al., 1992 ; Basgoz et al., 1992) . Furthermore, codon changes in AD1 and AD2 between clinical strains have been demonstrated (Roy et al., 1993 ; Meyer-Ko$ nig et al., 1998 b ; MeyerKo$ nig et al., 1998 a) . Since recombination within the gB gene leads to exchange of potentially immunodominant regions, one may consider recombination to be at least one mechanism involved in protection against the attack of the humoral immune response.
The mechanisms involved in the recombination processes of HCMV are not known. However, host cellular factors may be involved. This is supported by the fact that HCMV infection induces the expression of topoisomerase II, which is essential for DNA replication and is involved in double-strand breaks in the DNA helix (Benson & Huang, 1990) . Further studies should define the cellular factors involved in HCMV gB recombination.
